210 related articles for article (PubMed ID: 3145201)
1. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
Simoncsits A; Tjörnhammar ML; Kalman M; Cserpan I; Gafvelin G; Bartfai T
Eur J Biochem; 1988 Dec; 178(2):343-50. PubMed ID: 3145201
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and transcript size of the prepro-peptide VIP/PHM-27 in normal human tissue.
Schulte-Bockholt A; Meier DA; Hopp K; Stadelmann A; Otterson MF; Telford GL; Koch TR
Neurosci Lett; 1993 Dec; 164(1-2):101-4. PubMed ID: 8152582
[TBL] [Abstract][Full Text] [Related]
3. In situ hybridization reveals VIP precursor mRNA-containing neurons in monkey and rat neocortex.
Benson DL; Isackson PJ; Jones EG
Brain Res Mol Brain Res; 1991 Jan; 9(1-2):169-74. PubMed ID: 1850073
[TBL] [Abstract][Full Text] [Related]
4. Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP).
McFarlin DR; Lehn DA; Moran SM; MacDonald MJ; Epstein ML
Gene; 1995 Mar; 154(2):211-3. PubMed ID: 7890166
[TBL] [Abstract][Full Text] [Related]
5. Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.
Linder S; Barkhem T; Norberg A; Persson H; Schalling M; Hökfelt T; Magnusson G
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):605-9. PubMed ID: 3025882
[TBL] [Abstract][Full Text] [Related]
6. Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs.
Raingeaud J; Lavergne F; Lelievre V; Muller JM; Julien R; Cenatiempo Y
Biochimie; 1996; 78(1):14-25. PubMed ID: 8725006
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide: expression of the prohormone in bacterial cells.
DeLamarter JF; Buell GN; Kawashima E; Polak JM; Bloom SR
Peptides; 1985; 6 Suppl 1():95-102. PubMed ID: 2995945
[TBL] [Abstract][Full Text] [Related]
8. Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine.
Tse DL; Pang RT; Wong AO; Chan SM; Vaudry H; Chow BK
Endocrinology; 2002 Apr; 143(4):1327-36. PubMed ID: 11897689
[TBL] [Abstract][Full Text] [Related]
9. Structure of the human vasoactive intestinal polypeptide gene.
Tsukada T; Horovitch SJ; Montminy MR; Mandel G; Goodman RH
DNA; 1985 Aug; 4(4):293-300. PubMed ID: 3899557
[TBL] [Abstract][Full Text] [Related]
10. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.
Itoh N; Obata K; Yanaihara N; Okamoto H
Nature; 1983 Aug 11-17; 304(5926):547-9. PubMed ID: 6571696
[TBL] [Abstract][Full Text] [Related]
11. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.
Yamagami T; Ohsawa K; Nishizawa M; Inoue C; Gotoh E; Yanaihara N; Yamamoto H; Okamoto H
Ann N Y Acad Sci; 1988; 527():87-102. PubMed ID: 2839091
[TBL] [Abstract][Full Text] [Related]
12. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
13. Identification of a VIP-specific receptor in guinea pig tenia coli.
Teng BQ; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
[TBL] [Abstract][Full Text] [Related]
14. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
Fahrenkrug J
Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide precursors have highly potent bronchodilatory activity.
Ito O; Tachibana S
Peptides; 1991; 12(1):131-7. PubMed ID: 2052489
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a variant form of vasoactive intestinal polypeptide.
Gafvelin G; Andersson M; Dimaline R; Jörnvall H; Mutt V
Peptides; 1988; 9(3):469-74. PubMed ID: 2843830
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat.
Nishizawa M; Hayakawa Y; Yanaihara N; Okamoto H
FEBS Lett; 1985 Apr; 183(1):55-9. PubMed ID: 3838518
[TBL] [Abstract][Full Text] [Related]
19. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
Mikkelsen JD; Fahrenkrug J
Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
[TBL] [Abstract][Full Text] [Related]
20. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects.
Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T
Am J Physiol; 1987 Feb; 252(2 Pt 1):G182-9. PubMed ID: 3548423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
